In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte-colony stimulating factor following sublethal irradiation

British Journal of Haematology

Volumn 94, Issue 4, 1996, Pages 619-627

  Watanabe, Tsutomu ^a   Kelsey, Linda S ^a   Yan, Yun ^a   Brown, Gregory S ^a   Jackson, John D ^a   Ewel, Cynthia ^b   Talmadge, James E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Henri Beaufour Institute   (United States)

Author keywords

AcSDKP; G CSF; Haemoprotective; Progenitor cells; Sublethal irradiation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; TETRAPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW SUPPRESSION; COLONY FORMING CELL; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0029758395     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1853.x     Document Type: Article

References (32)

1. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R., Chauncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R. Bucker, C.D. (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Journal of Clinical Oncology, 13, 2547-2553.
2. Bogden, A.E., Carde, P., Paillette, E.D., Moreau, J.P., Tubiana, M. & Frindel, E. (1991) Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. Annals of the New York Academy of Sciences, 628, 126-139.
3. Bonnet, D., Césaire, R., Lemoine, F., Aoudjhane, M., Najman, A. & Guigon, M. (1992a) The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells. Experimantal Hematology, 20, 251-255.
4. Bonnet, D., Lemoine, F., Khoury, E. & Pradelles, P. (1992b) Reversible inhibitory effects and absence of toxicity of the tetrapeptide Acetyl-N-Ser-Lys-Pro (AcSDKP) in human long-term bone marrow culture. Experimental Hematology, 20, 1165-1169.
5. Bradley, T.R. & Hodgson, P. (1979) Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood, 54, 1446-1450.
6. Cashman, J.D., Eaves, A.C. & Eaves, C.J. (1994) The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism. Blood, 84, 1534-1542.
7. Cooper, S., Mantel, C. & Broxmeyer, H.E. (1994) Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1a. Experimental Hematology, 22, 186-193.
8. Crown, J., Jakubowski, A., Kemeny, N., Gordon, M., Gasparetto, C., Wong, G., Sheridan, C., Toner, G., Meisenberg, B., Botet, J., Applewhite, J., Sinha, S., Moore, M., Kelson, D., Buhles, W. & Gabrilove, J. (1991) A phase 1 trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood, 78, 1420-1427.
9. Dunlop, D.J., Wright, E.G., Lorimore, S., Graham, G.J., Holyoake, T., Kerr, D.J., Wolpe, S.D. & Pragnell, I.B. (1992) Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1a in vivo. Blood, 79, 2221-2225.
10. Frindel, E. & Guigon, M. (1977) Inhibition of CFU entry into cycle by a bone marrow extract. Experimental Hematology, 5, 74-76.
11. Grillon, C., Bonnet, D. & Mary, J.Y. (1993a) The tetrapeptide AcSerAspLysPro (seraspenide), a hematopoietic inhibitor, may reduce the in vivo toxicity of 3′-azide-3′-deoxythymidine to human hematopoietic progenitors. Stem Cells, 11, 455-464.
12. Grillon, C., Lenfant, M. & Wdzieczak-Bakala, J. (1993b) Optimization of cell culture for the evaluation of the biological activities of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro, a natural hemoregulatory factor. Growth Factors, 9, 133-138.
13. Guigon, M., Mary, J.Y., Enouf, J. & Frindel, E. (1982) Protection of mice against lethal doses of 1b-D-arabinofuranosylcytosine by pluripotent stem cell inhibitors. Cancer Research, 42, 638-641.
14. Hornung, R.L. & Longo, D.L. (1992) Hematopoietic stem cell depletion by restorative growth factor regimen during repeated high dose cyclophosphamide therapy. Blood, 80, 3-7.
15. Jackson, J.D., Yan, Y., Brunda, M.J., Kelsey, L.S. & Talmadge, J.E. (1995) Interleukin-12 enhances peripheral hematopoiesis in vivo. Blood, 85, 2371-2376.
16. Jackson, J.D., Yan, Y., Ewel, C. & Talmadge, J.E. (1996) Activity of acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures. Experimental Hematology, 24, 475-481.
17. Jacobsen, S.E.W., Keller, J.R., Ruscetti, E.W., Kondaiah, P., Roberts, A.B. & Falk, L.A. (1991) Bidirectional effects of transforming growth factor b (TGF-b) on colony-stimulating factor-induced human myclopoiesis in vitro: differential effects of distinct TGF-b isoforms. Blood, 78, 2239-2247.
18. Johnson, C.S., Keckler, D.J., Topper, M.I., Braunschweiger, P.G. & Furmanski, P. (1989) In vivo hematopoietic effects of recombinant interleukin-1a in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression with erythropoietin. Blood, 73, 678-683.
19. Lenfant, M., Itoh, K., Sakoda, H., Sotty, D., Sasaki, N.A., Wdzieczak-Bakala, J. & Mori, K.J. (1989) Enhancement of the adherence of hematopoietic stem cells to mouse bone marrow derived stromal cell line MS-1-T by the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro. Experimental Hematology, 17, 898-902.
20. Lieschke, G.J. & Burgess, A.W. (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New England Journal of Medicine, 327, 99-106.
21. Lord, B.I., Dexter, T.M., Clements, J.M., Hunter, M.A. & Gearing, A.J.H. (1992) Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood, 79, 2605-2609.
22. Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. & Frei, E., III. The Cancer and Leukemia Group B (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. New England Journal of Medicine, 331, 896-903.
23. Neta, R. & Oppenheim, J.J. (1991) Radioprotection with cytokines: learning from nature to cope with radiation damage. Cancer Cells, 3, 391-396.
24. Paukovits, W.R., Moser, M.H. & Paukovits, J.B. (1993) Pre-CFU-S quiescence and stem cell exhaustion after cytostatic drug treatment: protective effects of inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK). Blood. 81, 1755-1761.
25. Pradelles, P., Frobert, Y., Créminon, C., Liozon, E., Massé, A. & Frindel, E. (1990) Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analyzed by enzyme immunoassay. Biochemical and Biophysical Research Communications. 170, 986-993.
26. Rieger, K.J., Saez-Servent, N., Papet, M.P., Wdzieczak-Bakala, J., Morgat, J.L., Thierry, J., Voelter, W. & Lenfant, M. (1993) Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. Biochemical Journal. 296, 373-378.
27. Robinson, S., Lenfant, M., Wdzieczak-Bakala, J., Melville, J. & Riches, A. (1992) The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation. Cell Proliferation, 25, 623-632.
28. Thierry, J., Papet, M.P., Saez-Servent, N., Plissonneau-Haumont, J., Potler, P. & Lenfant, M. (1990) Synthesis and activity of NAcSerAspLysPro analogous on cellular interactions between T-cell and erythrocytes in rosette formation. Journal of Medicinal Chemistry, 33, 2122-2127.
29. Tubiana, M., Carde, P. & Frindel, E. (1993) Ways of minimizing hematopoietic damage induced by radiation and cytostatic drugs: the possible role of inhibitors. Radiotherapy and Oncology, 29, 1-17.
30. Vose, J.M. & Armitage, J.O. (1995) Clinical applications of hematopoietic growth factors. Journal of Clinical Oncology, 13, 1023-1035.
31. Watanabe, T., Brown, G.S., Kelsey, L.S., Yan, Y., Jackson, J.D., Ewel, C., Kessinger, A. & Talmadge, J.E. (1996) In vivo protective effects of tetrapeptide AcSDKP with or without granulocyte colony-stimulating factor on murine progenitor cells following sublethal irradiation. Experimental Hematology, in press.
32. Wood, W.C., Budman, D.R., Korzun, A.H., Cooper, M.R., Younger, J., Hart, R.D., Moore, A., Ellerton, J.A., Norton, L., Ferree, C.R., Ballow, A.C., Frei, E., III & Henderson, I.C. (1994) Dose and dose intensity of adjuvant chemotherapy for stage II. node-positive breast carcinoma. New England Journal of Medicine, 330, 1253-1259.